Keyphrases
Doxorubicin
100%
Functional Markers
100%
Molecular Markers
100%
Longitudinal Assessment
100%
Cardiovascular Toxicity
100%
Left Ventricular Ejection Fraction
35%
Arterial Stiffness
35%
Thrombospondin-1 (TSP-1)
35%
SERPINA3
35%
Anthracycline-induced Cardiotoxicity
14%
Therapy Cessation
14%
Age-matched
7%
Cardiovascular Events
7%
Cardiac Dysfunction
7%
Endothelial Dysfunction
7%
Young Males
7%
AIMS™
7%
Vascular Reactivity
7%
Murine Model
7%
Proteomic Analysis
7%
Phenylephrine
7%
Vascular Dysfunction
7%
Cardiotoxicity
7%
Aortic Tissue
7%
Cancer Survivors
7%
Male Mice
7%
Patient Plasma
7%
Cardiovascular Risk Stratification
7%
Cardiovascular Function
7%
Impaired Endothelial Function
7%
Endothelium-dependent Vasodilation
7%
Alpha-1-antichymotrypsin
7%
Vascular Toxicity
7%
Promising Biomarkers
7%
Medicine and Dentistry
Doxorubicin
100%
Molecular Marker
100%
Cardiovascular Toxicity
100%
Heart Left Ventricle Ejection Fraction
35%
Arterial Stiffness
35%
Thrombospondin 1
35%
Cardiotoxicity
21%
Biological Marker
14%
Ex Vivo
14%
Anthracycline
14%
Malignant Neoplasm
7%
Risk Stratification
7%
Endothelial Dysfunction
7%
Cardiovascular Risk
7%
Vasodilatation
7%
Cardiovascular System
7%
Population
7%
Endothelial Function
7%
Chemotherapy
7%
Proteomics
7%
Phenylephrine
7%
Blood Vessel Reactivity
7%
Aortic Tissue
7%
Cardiovascular Physiology
7%
Alpha 1 Antichymotrypsin
7%
INIS
toxicity
100%
evaluation
100%
doxorubicin
100%
stiffness
35%
patients
28%
therapy
21%
biological markers
14%
in vivo
14%
plasma
14%
reactivity
7%
levels
7%
cancer
7%
contraction
7%
tissues
7%
control
7%
risks
7%
comparative evaluations
7%
males
7%
mice
7%
populations
7%
endothelium
7%
vehicles
7%
stratification
7%
vasodilation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Molecular Marker
100%
Cardiovascular Toxicity
100%
Thrombospondin 1
35%
Cardiotoxicity
21%
Biological Marker
14%
Anthracycline
14%
Alpha 1 Antichymotrypsin
7%
Malignant Neoplasm
7%
Mouse
7%
Endothelial Dysfunction
7%
Cardiovascular Risk
7%
Phenylephrine
7%
Biochemistry, Genetics and Molecular Biology
Doxorubicin
100%
Genetic Marker
100%
Arterial Stiffness
35%
Heart Left Ventricle Ejection Fraction
35%
Thrombospondin 1
35%
Anthracycline
14%
Mouse
7%
Population
7%
Vasodilatation
7%
Proteomics
7%
Phenylephrine
7%
Alpha 1-Antichymotrypsin
7%
Blood Vessel Reactivity
7%
Cardiovascular Function
7%